3J3-21037-53860

Timeline

1. 2021-01-17
   Dose 1 — Moderna
2. 2021-01-18
   Registered in v-safe
3. 2021-01-18
   Health check-in — days 1–6 daily, dose 1

   Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness

   Adult check-in
4. 2021-01-19
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · Site: Pain · None

   Adult check-in
5. 2021-01-21
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · Headache

   Adult check-in
6. 2021-01-22
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · None

   Adult check-in
7. 2021-01-23
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · None

   Adult check-in
8. 2021-01-24
   Health check-in — day 7, dose 1

   Feeling: Good · None

   Adult check-in
9. 2021-02-02
   Health check-in — day 14, dose 1

   Feeling: Good

   Adult check-in
10. 2021-02-10
    Health check-in — day 21, dose 1

    Feeling: Good

    Adult check-in
11. 2021-02-13
    Dose 2 — Moderna
12. 2021-02-14
    Health check-in — days 1–6 daily, dose 2

    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities

    Adult check-in
13. 2021-02-17
    Health check-in — days 1–6 daily, dose 2

    Feeling: Good · Site: Pain · None

    Adult check-in
14. 2021-02-18
    Health check-in — days 1–6 daily, dose 2

    Feeling: Good · Headache

    Adult check-in
15. 2021-10-29
    Dose 3 — Moderna
16. 2021-11-05
    Survey response — day 7, dose 3

    MedDRA: Injection site pruritus, Rash, Rash erythematous, Rash pruritic, Rash vesicular — Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

    Free text: Rash is a 10x4cm area overlying R clavicle with broad erythema and scattered vesicles. Looks similar to contact dermatitis of poison oak or zoster, but area is intensely itchy and not painful. Mild itching of L deltoid (Inj site). No other skin sx.

    MedDRA releases: 2024-11 · check-in free text available
17. 2021-11-12
    Survey response — day 14, dose 3

    MedDRA: Fatigue, Headache, Impaired work ability, Nausea, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

    Free text: Zoster - symptoms began 11/4, rash appeared 11/5, symptoms this week have included zoster rash below R clavicle, severe headaches, fatigue and mild nausea. I did not go to work because of the contagious nature of this dx, not because of sx severity.

    MedDRA releases: 2024-11 · check-in free text available
18. 2021-11-12
    Report sent to call center — day 14, dose 3

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Telehealth, virtual health, or email health consultation · 1 call case(s)
19. 2021-11-17
    Call successful

    Participant prefers to complete VAERS report online